Report Type : Therapy Reports
Report Category : Cardiovascular
Report Subcategory : Pulmonary Arterial Hypertension
Price : $2999.00
Date : July 2021
Pulmonary Arterial Hypertension : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Top 50 Key Players:
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Bayer AG
Novartis AG
Merck & Co Inc
GlaxoSmithKline Plc
Bristol-Myers Squibb Co
Gilead Sciences Inc
Eli Lilly and Co
Boehringer Ingelheim International GmbH
Biogen Inc
Chiesi Farmaceutici SpA
United Therapeutics Corp
Mochida Pharmaceutical Co Ltd
Handok Inc
Lee's Pharmaceutical Holdings Ltd
Minapharm Pharmaceuticals & Chemical Industries
Insys Therapeutics Inc
Acceleron Pharma Inc
Correvio Pharma Corp
Reata Pharmaceuticals Inc
Cipher Pharmaceuticals Inc
C4X Discovery Holdings Plc
Mezzion Pharma Co Ltd
AVEO Oncology Inc
Anterogen Co Ltd
SteadyMed Ltd
PhaseBio Pharmaceuticals Inc
Pluristem Therapeutics Inc
Actelion Pharmaceuticals Ltd
Janssen Global Services LLC
APT Therapeutics Inc
Northern Therapeutics Inc
AVEO Pharmaceuticals Inc
Aqualung Therapeutics Corp
Gmax Biopharm Ltd
Galectin Therapeutics Inc
GenThera Inc
Excubio Pharmaceuticals Inc
Morphogen-IX Ltd
Abivax SA
Reviva Pharmaceuticals Inc
Complexa Inc
Aerogen Ltd
Government Japan
Gossamer Bio Inc
Roivant Sciences Ltd
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Sandberg Development AB
Respira Therapeutics Inc